Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2017 1
2018 3
2019 2
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen.
Timmers M, Roex G, Wang Y, Campillo-Davo D, Van Tendeloo VFI, Chu Y, Berneman ZN, Luo F, Van Acker HH, Anguille S. Timmers M, et al. Among authors: campillo davo d. Front Immunol. 2019 Jul 16;10:1613. doi: 10.3389/fimmu.2019.01613. eCollection 2019. Front Immunol. 2019. PMID: 31379824 Free PMC article. Review.
Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia.
Van Acker HH, Versteven M, Lichtenegger FS, Roex G, Campillo-Davo D, Lion E, Subklewe M, Van Tendeloo VF, Berneman ZN, Anguille S. Van Acker HH, et al. Among authors: campillo davo d. J Clin Med. 2019 Apr 27;8(5):579. doi: 10.3390/jcm8050579. J Clin Med. 2019. PMID: 31035598 Free PMC article. Review.
The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy.
Van Acker HH, Campillo-Davo D, Roex G, Versteven M, Smits EL, Van Tendeloo VF. Van Acker HH, et al. Among authors: campillo davo d. Cytokine Growth Factor Rev. 2018 Jun;41:54-64. doi: 10.1016/j.cytogfr.2018.05.002. Epub 2018 May 16. Cytokine Growth Factor Rev. 2018. PMID: 29773448 Review.
A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches.
Versteven M, Van den Bergh JMJ, Broos K, Fujiki F, Campillo-Davo D, De Reu H, Morimoto S, Lecocq Q, Keyaerts M, Berneman Z, Sugiyama H, Van Tendeloo VFI, Breckpot K, Lion E. Versteven M, et al. Among authors: campillo davo d. Oncotarget. 2018 Jun 12;9(45):27797-27808. doi: 10.18632/oncotarget.25591. eCollection 2018 Jun 12. Oncotarget. 2018. PMID: 29963238 Free PMC article.
Cellular immunotherapy: a clinical state-of-the-art of a new paradigm for cancer treatment.
Rodríguez Pérez Á, Campillo-Davo D, Van Tendeloo VFI, Benítez-Ribas D. Rodríguez Pérez Á, et al. Among authors: campillo davo d. Clin Transl Oncol. 2020 Nov;22(11):1923-1937. doi: 10.1007/s12094-020-02344-4. Epub 2020 Apr 7. Clin Transl Oncol. 2020. PMID: 32266674 Review.
Efficient and Non-genotoxic RNA-Based Engineering of Human T Cells Using Tumor-Specific T Cell Receptors With Minimal TCR Mispairing.
Campillo-Davo D, Fujiki F, Van den Bergh JMJ, De Reu H, Smits ELJM, Goossens H, Sugiyama H, Lion E, Berneman ZN, Van Tendeloo V. Campillo-Davo D, et al. Front Immunol. 2018 Nov 7;9:2503. doi: 10.3389/fimmu.2018.02503. eCollection 2018. Front Immunol. 2018. PMID: 30464762 Free PMC article.
An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis.
Bossini-Castillo L, Campillo-Davó D, López-Isac E, Carmona FD, Simeon CP, Carreira P, Callejas-Rubio JL, Castellví I, Fernández-Nebro A, Rodríguez-Rodríguez L, Rubio-Rivas M, García-Hernández FJ, Madroñero AB, Beretta L, Santaniello A, Lunardi C, Airó P, Hoffmann-Vold AM, Kreuter A, Riemekasten G, Witte T, Hunzelmann N, Vonk MC, Voskuyl AE, de Vries-Bouwstra J, Shiels P, Herrick A, Worthington J, Radstake TRDJ, Martin J; Spanish Scleroderma Group. Bossini-Castillo L, et al. Among authors: campillo davo d. J Rheumatol. 2017 Oct;44(10):1453-1457. doi: 10.3899/jrheum.161369. Epub 2017 Jul 1. J Rheumatol. 2017. PMID: 28668810
MRGPRX2 and Immediate Drug Hypersensitivity: Insights from Cultured Human Mast Cells.
Elst J, Sabato V, Faber MA, Bridts CH, Mertens C, Van Houdt M, Van Gasse AL, Hagendorens MM, Van Tendeloo V, Maurer M, Campillo-Davo D, Timmermans JP, Pintelon I, Ebo DG. Elst J, et al. Among authors: campillo davo d. J Investig Allergol Clin Immunol. 2020 Jul 30:0. doi: 10.18176/jiaci.0557. Online ahead of print. J Investig Allergol Clin Immunol. 2020. PMID: 32732181 Free article.
PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivity.
van Ens D, Mousset CM, Hutten TJA, van der Waart AB, Campillo-Davo D, van der Heijden S, Vodegel D, Fredrix H, Woestenenk R, Parga-Vidal L, Jansen JH, Schaap NPM, Lion E, Dolstra H, Hobo W. van Ens D, et al. Among authors: campillo davo d. Bone Marrow Transplant. 2020 Dec;55(12):2308-2318. doi: 10.1038/s41409-020-0966-6. Epub 2020 Jun 11. Bone Marrow Transplant. 2020. PMID: 32528120 Free article.
The antihypertensive drug hydralazine activates the intrinsic pathway of apoptosis and causes DNA damage in leukemic T cells.
Ruiz-Magaña MJ, Martínez-Aguilar R, Lucendo E, Campillo-Davo D, Schulze-Osthoff K, Ruiz-Ruiz C. Ruiz-Magaña MJ, et al. Among authors: campillo davo d. Oncotarget. 2016 Apr 19;7(16):21875-86. doi: 10.18632/oncotarget.7871. Oncotarget. 2016. PMID: 26942461 Free PMC article.
13 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page